Key facts
- Novo Nordisk has rebranded to 'Novo'.
- The change reflects a broader focus beyond diabetes and obesity treatments.
Novo Nordisk, the pharmaceutical company behind the popular weight-loss drug Ozempic, has rebranded to 'Novo'. The change reflects the company's broader focus beyond its diabetes and obesity treatments.